Molecular Diagnostics
Measurement of Circulating CRP Reduces Unnecessary Antibiotic Treatments
By determining levels of C-reactive protein (CRP) in the blood, it was possible to reduce the number of unnecessary prescriptions for antibiotics that were issued in the United Kingdom to individuals experiencing flare-ups of their chronic obstructive pulmonary disease (COPD). More...22 Jul 2019
Low-Frequency TP53 Gene Mutations Also Found in Healthy Women
Worldwide, more than 250,000 new cases of ovarian cancer are diagnosed each year, and two-thirds of these women die from the disease. This high mortality is largely due to the high frequency of metastasis before diagnosis and a lack of effective screening and early detection methods. More...19 Jul 2019
Blood Test Complements Colonoscopy for Lynch Syndrome Patients
Lynch syndrome (LS) subjects are genetically predisposed to a high risk for colorectal cancer (CRC) and regular colonoscopy is currently the only CRC screening option recommended for these subjects, although compliance is suboptimal. More...16 Jul 2019
![Image: A scanning electron micrograph (SEM) of a human T-cell from the immune system of a healthy donor (Photo courtesy of [U.S.] NIAID).](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2019-07-15/GMS-114.jpg "Image: A scanning electron micrograph (SEM) of a human T-cell from the immune system of a healthy donor (Photo courtesy of [U.S.] NIAID).")
Regulatory T-cell Responsiveness Predicts Risk of Cancer Relapse
The risk of future breast cancer relapse can be predicted by analyzing the signaling responsiveness of peripheral blood Treg II cells (CD45RA−FOXP3hi Treg cells) to immunosuppressive T helper type 1 (TH1) and T helper type 2 (TH2) cytokines. More...15 Jul 2019
Protein Linked to Aggressive Skin Cancer
Almost 300,000 people worldwide develop malignant melanoma each year. The disease is the most serious form of skin cancer and the number of cases reported annually is increasing, making skin cancer one of Sweden's most common forms of cancer. More...10 Jul 2019
New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
New
Gold Member
Total Triiodothyronine Assay
T3 EIA 96 Kit
New
Dengue Test
Lab Rapid Dengue NS1
In Other News
Test Determines If Cancer Patients Require Chemotherapy
Automated Approach Predicts Alzheimer's Disease Risk
Levels of NfL Increase Accuracy of Stroke Risk Prediction
Whole-Blood Testing Diagnoses Acute Zika Virus Infections
Metastases May Form Early in Development of Colorectal Cancer
Fetal Genetic Variants Implicated in Spontaneous Preterm Birth Risk
New Genetic Link to Premenopausal Breast Cancer Discovered
New Biomarker Test Improves Diagnosis of Ovarian Cancer
Graphene-Based Transistor Detects Bacteria in Microdroplets
Researchers Use NIV Methods for Diagnosis of Endometrial Cancer
Novel Nanoparticle Sensor Array Detects Early Stages of Cancer
Alzheimer Disease Stratified by APOE Genotype
Pathogenic Variant Carriers Missed by Current Genetic Testing
RT-LAMP Used to Genotype and Diagnose Chikungunya
Immune-Related Gene Implicated in Chronic Candida Infection Risk
Clinical Metagenomic Sequencing Improves Diagnosis of Neurological Infections
Identifying Colorectal Cancer Subtypes Improves Treatment Decisions
Blood Drop Assay Designed for Monitoring Antimalarial Drug Resistance
Cholera Diagnosed from Dried Spotted Filter Paper
Novel Methylated DNA Markers Assay Detects Cancer
Biomarker Found for Celiac Patients on Gluten-Free Diet
Study Results Validate Use of Tumor Markers to Treat Metastatic Cancer
Immunodiagnostic Test Predicts Progression of Pancreatic Cyst to Cancer
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
